DTC Broadcast Ad Major Statement Checker
A TV or radio ad for a prescription drug must state the drug's major risks, and since 2024 FDA has set rules for how: plain words, the same words spoken and shown on screen, and nothing distracting while they play. Paste a script to see how it measures up against the drug's label.
Pick the drug, then paste a broadcast ad script. The check shows which boxed warning, contraindication and warnings from the label the major statement names, how the script reads against FDA's clear, conspicuous and neutral standards, and whether it makes adequate provision for the full labeling.
Or try a sample: Qelbree's 2025 TV ad, which FDA said had โfrequent scene changes during the presentation of the major statementโ.
The boxed warning, contraindications and warnings and precautions come from the current label's SPL file on DailyMed. DailyMed, National Library of Medicine
About the major statement checker
The rules it reads
- The major statement. A broadcast ad must present โthe major side effects and contraindicationsโ of the drug in its audio, or audio and visual, parts, and either a brief summary of all the risks or adequate provision for the labeling. 21 CFR 202.1(e)(1)(i).
- Clear, conspicuous and neutral. For TV and radio ads to consumers, the major statement must use consumer-friendly language; its audio must be at least as understandable as the rest of the ad; on TV it must be shown as text while it is spoken (dual modality), legibly; and nothing during it may interfere with comprehension. 21 CFR 202.1(e)(1)(ii), added by the final rule of November 21, 2023 (88 FR 80958), effective May 20, 2024, with compliance from November 20, 2024.
- Adequate provision. FDA's 1999 guidance describes four parts: a toll-free number, a print ad or brochures for people without internet, a website with the labeling, and a statement that doctors or pharmacists can tell you more.
Frequently asked questions
- Is my script uploaded?
- No. The script you paste or the file you open is read in this browser tab and never sent anywhere. Only the drug and the format are in the page address.
- How is the major statement found?
- The script is split into frames at timecodes (00:22), frame numbers or blank lines. The major statement is taken to run from the first to the last frame with risk wording, such as โmay causeโ, โseriousโ, โdo not takeโ, โside effectsโ or โtell your doctorโ. Check the frames it shows; trim the script if it picked up a line that is not part of it.
- How are the label's risks matched?
- Each risk is reduced to its distinctive words: โSuicidal thoughts and behaviorsโ, or a contraindication's drug class and condition. Words like patients, risk and serious are set aside, and the plain words consumer ads use count for the technical ones (allergic for hypersensitivity, blood clots for thrombosis, liver for hepatotoxicity). A risk is named when half or more of its words are in the major statement. No AI model is used.
- Does a pass mean the ad complies?
- No. These are heuristics for a reviewer, not a legal determination. Size and contrast of on-screen text, how long it stays up, volume, and whether music or scenes distract all need the finished video. FDA decides compliance, and OPDP letters show it weighs the ad as a whole.
- Is adequate provision still allowed?
- Yes, as of November 2026: 21 CFR 202.1(e)(1)(i)(B) still lets a broadcast ad make adequate provision for the labeling instead of a full brief summary. FDA's 2026 Unified Agenda lists a proposed rule (RIN 0910-AJ14) that would remove that option; it had not been published when this page was written.